Synapse - Works

Results (2639)

Tositumomab and iodine I 131 tositumomab (BEXXAR (R) therapeutic regimen) produces long-term durable responses in heavily pretreated patients with relapsed, refractory, and transformed low-grade non-hodgkin's lymphoma (NHL

Meeting Abstract

Knox, S. K.; Meredith, R. F.; Coleman, M.; Kaminski, M. S.; Zelenetz, A. D.; Vose, J. M.
International Journal of Radiation Oncology, Biology, Physics (2004)

Fulltext@MSK | Save

Tositumomab and iodine I 131 tositumomab (The BEXXAR (R) therapeutic regimen) produced ongoing, durable remissions of more than 5 years in 9 patients with non-Hodgkin's lymphoma (NHL) in a pivotal study of patients refractory to their last chemotherapy

Meeting Abstract

Kaminski, M. S.; Zelenetz, A. D.; Press, O. W.; Saleh, M. N.; Leonard, J. P.; Fehrenbacher, L.; Lister, T. A.; Kroll, S.; Wahl, R. L.; Knox, S. J.; more...
Blood (2004)

Fulltext@MSK | Save

Primary Mediastinal Large B cell Lymphoma: Elucidating optimal therapy and prognostic factors; an analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980-1999

Meeting Abstract

Hamlin, P. A.; Portlock, C. S.; Straus, D. J.; Noy, A.; Horwitz, S. M.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2004)

Fulltext@MSK | Save

The follicular lymphoma international prognostic index (FLIPI) is superior to WHO/REAL histological grade for identifying high-risk patients: A retrospective review of the MSKCC experience in 260 patients with follicular lymphoma

Meeting Abstract

Halaas, J. L.; Teruya-Feldstein, J.; Filippa, D. A.; Moskowitz, C.; Naresh, K. N.; Zelenetz, A. D.
Blood (2004)

Fulltext@MSK | Save

Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-cell lymphoma (DLBCL)

Meeting Abstract

Halaas, J. L.; Moskowitz, C. H.; Noy, A.; Portlock, C.; Horwitz, S.; Straus, D.; O'connor, O.; Yahalom, J.; Zelenetz, A. D.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Tositumomab and iodine I 131 tositumomab (the BEXXAR (R) therapeutic regimen) shows efficacy in elderly patients (pts) with relapsed/refractory low-grade (LG), follicular, and transformed non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Gregory, S. A.; Zelenetz, A.; Knox, S. J.; Vose, J.; Leonard, J. P.; Kaminski, M.
Blood (2004)

Fulltext@MSK | Save

The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Gregory, S. A.; Leonard, J. P.; Knox, S. J.; Zelenetz, A. D.; Armitage, J.; Kaminiski, M.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Evolution of Rituximab as "standard" therapy in patients (pts) with newly diagnosed follicular (FL), mantle cell (MCL), and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in 5 United States comprehensive cancer centers: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project

Meeting Abstract

Friedberg, J. W.; Kho, M. E.; Lepisto, E. M.; Rodriguez, M. A.; TerVeer, A.; LaCasce, A. S.; Nademanee, A. P.; Millenson, M.; Czuczman, M.; Niland, J.; more...
Blood (2004)

Fulltext@MSK | Save

Clinical outcome correlations of genomic gains and losses in diffuse large B-cell lymphoma by array-CGH

Meeting Abstract

Chen, W. Y.; Olshen, A.; Chaganti, S.; Halaas, J.; Zelenetz, A. D.; Feldstein, J.; Houldsworth, J.; Chaganti, R. S. K.
Blood (2004)

Fulltext@MSK | Save

Bronchial-associated lymphoid tissue (BALT) lymphoma: Characteristics and treatment outcome of 19 cases

Meeting Abstract

Beal, K. P.; Portlock, C.; Yahalom, J.
Blood (2004)

Fulltext@MSK | Save